dacarbazine and Melanoma, Amelanotic

dacarbazine has been researched along with Melanoma, Amelanotic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Beberok, A; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D	1
Ihn, H; Inoue, Y; Ishihara, T; Kageshita, T; Kato, H	1
Asano, T; Hayakawa, M; Horiguchi, A; Shirotake, S; Sumitomo, M; Tasaki, S; Tobe, M; Yoshii, T	1
Bhawan, J; Demierre, MF; Karakis, I; McGeeney, B; Thiele, JJ; Wolpowitz, D	1
Bedikian, A; Benjamin, R; Buzaid, AC; Colome, M; Eton, O; Lee, JE; Lee, JJ; Legha, SS; Mansfield, P; Papadopoulos, N; Plager, C; Rice, J; Ring, S; Ross, M; Strom, E	1

Trials

1 trial(s) available for dacarbazine and Melanoma, Amelanotic

Article	Year
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases. Melanoma research, 1998, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Melanoma, Amelanotic; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Time Factors; Treatment Outcome; Vinblastine	1998

Article

Year

Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.

Melanoma research, 1998, Volume: 8, Issue:6

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Melanoma, Amelanotic; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Recombinant Proteins; Skin Neoplasms; Time Factors; Treatment Outcome; Vinblastine

1998

Other Studies

4 other study(ies) available for dacarbazine and Melanoma, Amelanotic

Article	Year
Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes. Pathology oncology research : POR, 2020, Volume: 26, Issue:3 Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Dacarbazine; DNA Damage; Glutathione; Humans; Melanoma, Amelanotic; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins B-raf	2020
Amelanotic malignant melanoma where primary lesion was discovered 5 years after metastasis in the lymph node. The Journal of dermatology, 2010, Volume: 37, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Foot Diseases; Heel; Humans; Lymphatic Metastasis; Male; Melanoma, Amelanotic; Middle Aged; Neoplasm Staging; Prognosis; Skin Neoplasms; Tomography, Emission-Computed; Vincristine	2010
[Case of primary amelanotic malignant melanoma of the female urethra]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2010, Volume: 101, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Female; Humans; Interferon-beta; Melanoma, Amelanotic; Middle Aged; Nimustine; Treatment Outcome; Urethra; Urethral Neoplasms; Urogenital Surgical Procedures; Vincristine	2010
Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement. Archives of neurology, 2007, Volume: 64, Issue:12 Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Dexamethasone; Humans; Hypopigmentation; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Melanoma, Amelanotic; Middle Aged; Neurologic Examination; Skin Neoplasms; Temozolomide	2007